Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Evidence of Buprenorphine-precipitated Withdrawal in Persons Who Use Fentanyl
Neil B. Varshneya, Ashish P. Thakrar, J. Gregory Hobelmann, et al.
Journal of Addiction Medicine (2021) Vol. 16, Iss. 4, pp. e265-e268
Open Access | Times Cited: 58

Showing 26-50 of 58 citing articles:

Opioid agonist treatment initiation and linkage for hospitalized patients seen by a substance use disorder consultation service
Courtney Nordeck, Christopher Welsh, Robert P. Schwartz, et al.
Drug and Alcohol Dependence Reports (2022) Vol. 2, pp. 100031-100031
Open Access | Times Cited: 14
Opioids and Opioid Use Disorder in Pregnancy
Aalok R. Sanjanwala, Grace Lim, Elizabeth E. Krans
Obstetrics and Gynecology Clinics of North America (2023) Vol. 50, Iss. 1, pp. 229-240
Closed Access | Times Cited: 8
Changes In County-Level Access To Medications For Opioid Use Disorder After Medicare Coverage Of Methadone Treatment Began
Samantha J. Harris, Courtney R. Yarbrough, Amanda J. Abraham
Health Affairs (2023) Vol. 42, Iss. 7, pp. 991-996
Open Access | Times Cited: 8
Dose titration with the glucagon-like peptide-1 agonist, liraglutide, reduces cue- and drug-induced heroin seeking in high drug-taking rats
Brianna Evans, Brooke Stoltzfus, Nikhil Acharya, et al.
Brain Research Bulletin (2022) Vol. 189, pp. 163-173
Open Access | Times Cited: 12
Inpatient Low-dose Transitions From Full Agonist Opioids Including Methadone Onto Long-acting Depot Buprenorphine: Case Series From a Multicenter Clinical Trial
Nikhil Seval, Johnathan Nunez, Prerana Roth, et al.
Journal of Addiction Medicine (2023) Vol. 17, Iss. 4, pp. e232-e239
Closed Access | Times Cited: 7
Low-Dose Initiation of Buprenorphine: A Narrative Review
Amber N. Edinoff, Omar H. Fahmy, Noah J Spillers, et al.
Current Pain and Headache Reports (2023) Vol. 27, Iss. 7, pp. 175-181
Closed Access | Times Cited: 7
Buprenorphine prescribing and treatment accessibility in response to regulation changes due to the COVID-19 public health emergency
Taylor J Paiva, Rachel Wightman, Kristen St. John, et al.
Journal of Substance Use and Addiction Treatment (2024) Vol. 162, pp. 209382-209382
Closed Access | Times Cited: 2
Evolution of the substance use landscape: Implications for contingency management
Shelby Goodwin, Kimberly C. Kirby, Bethany R. Raiff
Journal of Applied Behavior Analysis (2024) Vol. 58, Iss. 1, pp. 36-55
Open Access | Times Cited: 2
Longitudinal patterns of use of stimulants and opioids in the AIDS linked to the IntraVenous experience cohort, 2005–2019
Jacqueline E. Rudolph, Javier Cepeda, Jacquie Astemborski, et al.
International Journal of Drug Policy (2024) Vol. 126, pp. 104364-104364
Closed Access | Times Cited: 2
Fentanyl, Heroin, Methamphetamine, and Cocaine Analyte Concentrations in Urine Drug Testing Specimens
Andrew S. Huhn, Penn Whitley, B. Levi Bolin, et al.
JAMA Network Open (2024) Vol. 7, Iss. 10, pp. e2441063-e2441063
Open Access | Times Cited: 2
Attitudes on Methadone Utilization in the Emergency Department: A Physician Cross-sectional Study
Jessica Heil, Valerie Ganetsky, Matthew Salzman, et al.
Western Journal of Emergency Medicine (2022) Vol. 23, Iss. 3, pp. 386-395
Open Access | Times Cited: 9
Structurally diverse fentanyl analogs yield differential locomotor activities in mice
Neil B. Varshneya, D. Matthew Walentiny, David L. Stevens, et al.
Pharmacology Biochemistry and Behavior (2022) Vol. 222, pp. 173496-173496
Open Access | Times Cited: 9
Enhancing Patient Choice: Using Self-administered Intranasal Naloxone for Novel Rapid Buprenorphine Initiation
Adam Randall, Ilana Hull, Stephen A. Martin
Journal of Addiction Medicine (2022) Vol. 17, Iss. 2, pp. 237-240
Open Access | Times Cited: 8
Variability in opioid use disorder clinical presentations and treatment in the emergency department: A mixed-methods study
Sophia Faude, M. Kit Delgado, Jeanmarie Perrone, et al.
The American Journal of Emergency Medicine (2023) Vol. 66, pp. 53-60
Open Access | Times Cited: 4
Trends in Self-Reported Fentanyl and Other Illicit Substance Use in South Carolina Emergency Department Patients, 2020-2022
Suzanne M. Lane, Lindsey Jennings, Sarah Gainey, et al.
Journal of Emergency Medicine (2023) Vol. 65, Iss. 6, pp. e534-e541
Closed Access | Times Cited: 4
Factors that distinguish opioid withdrawal during induction with buprenorphine microdosing: a configurational analysis
Kathleen K. Adams, Edward J. Miech, Diana M Sobieraj
Addiction Science & Clinical Practice (2022) Vol. 17, Iss. 1
Open Access | Times Cited: 7
Hospitalist perspectives on buprenorphine treatment for inpatients with opioid use disorder
Megan K. Reed, Vignesh Murali, Nazanin Sarpoulaki, et al.
Drug and Alcohol Dependence Reports (2022) Vol. 5, pp. 100106-100106
Open Access | Times Cited: 7
Case Report: Buprenorphine-precipitated fentanyl withdrawal treated with high-dose buprenorphine
Nicholas L. Bormann, Antony Gout, Vicki Kijewski, et al.
F1000Research (2023) Vol. 11, pp. 487-487
Open Access | Times Cited: 4
Low-dose buprenorphine initiation and treatment continuation among hospitalized patients with opioid dependence: A retrospective cohort study
Benjamin T. Hayes, Phoebe Li, Tess Nienaltow, et al.
Journal of Substance Use and Addiction Treatment (2023) Vol. 158, pp. 209261-209261
Closed Access | Times Cited: 4
Effects of CB1 receptor negative allosteric modulator Org27569 on oxycodone withdrawal symptoms in mice
Rhianne L. Scicluna, Nicholas A. Everett, Connie J. Badolato, et al.
Psychopharmacology (2024) Vol. 241, Iss. 8, pp. 1705-1717
Open Access | Times Cited: 1
Methadone Initiation in the Emergency Department for Opioid Use Disorder
Daniel Wolfson, Roz King, Miles Lamberson, et al.
Western Journal of Emergency Medicine (2024) Vol. 25, Iss. 5
Open Access | Times Cited: 1
The Impact of High-Potency Synthetic Opioids on Pharmacotherapies for Opioid Use Disorder: A Scoping Review
Oluwole Jegede, João P. De Aquino, Connie Hsaio, et al.
Journal of Addiction Medicine (2024) Vol. 18, Iss. 5, pp. 499-510
Closed Access | Times Cited: 1
Ketamine-assisted buprenorphine initiation: a pilot case series
Lucinda A. Grande, Tom Hutch, Keira Jack, et al.
Addiction Science & Clinical Practice (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 1
Hyperactivity in Mice Induced by Opioid Agonists with Partial Intrinsic Efficacy and Biased Agonism Administered Alone and in Combination with Morphine
Agnes Acevedo‐Canabal, Travis W. Grim, Cullen L. Schmid, et al.
Biomolecules (2023) Vol. 13, Iss. 6, pp. 935-935
Open Access | Times Cited: 3
Buprenorphine deregulation as an opioid crisis policy response - A comparative analysis between France and the United States
Abhimanyu Sud, Kellia Chiu, Joseph Friedman, et al.
International Journal of Drug Policy (2023) Vol. 120, pp. 104161-104161
Open Access | Times Cited: 3

Scroll to top